Not applicableApproved For MarketingNCT03154437What this trial is testingAn Expanded Access Program of Emicizumab in Participants With Hemophilia A With InhibitorsWho this might be right forHemophilia A Genentech, Inc.
Not applicableStudy completedNCT00166309What this trial is testingThe FEIBA NovoSeven Comparative StudyWho this might be right forSevere Hemophilia A With an Inhibitor Skane University Hospital 60
Early research (Phase 1)Looking for participantsNCT06703606What this trial is testingLearn About How Changing Therapy From Emicizumab to Marstacimab Affects People With the Severe Hemophilia A.Who this might be right forSevere Hemophilia A Pfizer 15
Testing effectiveness (Phase 2)Study completedNCT00108758What this trial is testingEfficacy of NovoSeven® in Bleeding Prophylaxis in HemophiliaWho this might be right forCongenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors Novo Nordisk A/S 23
Large-scale testing (Phase 3)Study completedNCT02622321What this trial is testingEvaluate the Efficacy, Safety, and Pharmacokinetics of Prophylactic Emicizumab Versus no Prophylaxis in Hemophilia A Participants With InhibitorsWho this might be right forHemophilia A Hoffmann-La Roche 113
Large-scale testing (Phase 3)Study completedNCT05878938What this trial is testingA Research Study Looking at How Safe it is to Switch From Emicizumab to Mim8 in People With Haemophilia A (FRONTIER 5)Who this might be right forHaemophilia AHaemophilia A With Inhibitors Novo Nordisk A/S 61
Not applicableUnknownNCT01856751What this trial is testingUse of a TGA and TEM in the Assessment of the Efficacy of Treatment With APCC or rFVIIaWho this might be right forHaemophilia Stowarzyszenie Pomocy Chorym na Zakrzepicę i Skazy Krwotoczne Thrombus 80
Testing effectiveness (Phase 2)UnknownNCT04592692What this trial is testingA Pharmacokinetic and Clotting Activity Study of FVIII-PEGLipWho this might be right forHemophilia A With Inhibitor Ascension Healthcare Development Limited 20
Not applicableStudy completedNCT01586936What this trial is testingNon-Interventional Study of NovoSeven® Used as On-demand Treatment of Bleeds in Patients With Haemophilia A and B With InhibitorsWho this might be right forCongenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors Novo Nordisk A/S 9
Testing effectiveness (Phase 2)Ended earlyNCT04541628What this trial is testingSafety & Efficacy of Encapsulated Allogeneic FVIII Cell Therapy in Haemophilia AWho this might be right forHemophilia A Eli Lilly and Company 3
Not applicableStudy completedNCT01579968What this trial is testingNon-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors When Undergoing SurgeryWho this might be right forCongenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors Novo Nordisk A/S 86
Early research (Phase 1)Study completedNCT01563471What this trial is testingSafety and Tolerability of Intravenous Doses of Activated Recombinant Human Factor VII in Healthy VolunteersWho this might be right forCongenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors+1 more Novo Nordisk A/S 39
Not applicableUnknownNCT04805801What this trial is testingThe Safety of Emicizumab SC Injection in Korean Hemophilia A Patients With/Without FVIII InhibitorsWho this might be right forHemophilia A With InhibitorHemophilia A Without Inhibitor JW Pharmaceutical 17
Not applicableEnded earlyNCT00212472What this trial is testingInternational Immune Tolerance StudyWho this might be right forHemophilia A With Inhibitors New York Presbyterian Hospital 134
Large-scale testing (Phase 3)Ended earlyNCT00306670What this trial is testingTrial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia AWho this might be right forHemophilia A Georgetown University 2
Not applicableWithdrawnNCT03002480What this trial is testingIndividualizing Hemophilia Bypassing Agent Therapy Utilizing ThromboelastographyWho this might be right forHemophilia a with Inhibitors Children's Hospital Los Angeles
Testing effectiveness (Phase 2)Study completedNCT05421429What this trial is testingKN057 Multiple Dose Study in Moderately Severe to Severe HemophiliaWho this might be right forHemophilia Suzhou Alphamab Co., Ltd. 24
Large-scale testing (Phase 3)Study completedNCT03935334What this trial is testingClinical Trial Comparing a Biosimilar Eptacog Alfa With Novoseven, in Patients With Hemophilia With InhibitorsWho this might be right forHemophilia A or B With Inhibitor AryoGen Pharmed Co. 48
Large-scale testing (Phase 3)Study completedNCT03191799What this trial is testingEvaluate the Safety and Tolerability of Prophylactic Emicizumab in Hemophilia A Patients With InhibitorsWho this might be right forHemophilia A Hoffmann-La Roche 195
Post-approval studies (Phase 4)Study completedNCT03093480What this trial is testingEvaluate Efficacy of rFVIIIFc for Immune Tolerance Induction (ITI) in Severe Hemophilia A Participants With Inhibitors Undergoing the First ITI Treatment (verITI-8 Study)Who this might be right forHemophilia A With Inhibitors Bioverativ, a Sanofi company 16